| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 128.341 | 79 |
| GSM780708 | Untreated after 4 days (C2_1) | 162.257 | 81 |
| GSM780709 | Untreated after 4 days (C3_1) | 126.707 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 124.866 | 78 |
| GSM780720 | Untreated after 4 days (C2_2) | 136.088 | 79 |
| GSM780721 | Untreated after 4 days (C3_2) | 132.819 | 79 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 149.736 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 119.544 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 131.315 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 126.078 | 78 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 124.42 | 78 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 122.678 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 118.484 | 78 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 120.634 | 78 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 101.729 | 75 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 92.5519 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 114.669 | 77 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 111.669 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 124.932 | 78 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 120.92 | 78 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 118.732 | 78 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 129.937 | 79 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 109.745 | 77 |